20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Natera Inc (NTRA) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Austin, United States with about 6,135 employees. Its market capitalization is roughly $53 billion. In the fiscal year ended 2025-12-31, NTRA reported $2.3B in revenue and ($208M) in net income.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Interactive charts & full statements → Open the NTRA valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.7B | $2.3B | $1.7B | $1.1B | $820M | $625M | $391M | $302M | $258M | $211M | $217M | $190M | $159M | $55M | $14M |
| Gross Profit | $1.8B | $1.5B | $1.0B | $493M | $364M | $307M | $187M | $127M | $92M | $71M | $82M | $78M | $81M | $18M | $3M |
| Gross Margin % | 65.2% | 64.8% | 60.3% | 45.5% | 44.4% | 49.1% | 47.9% | 42.0% | 35.5% | 33.8% | 37.5% | 40.7% | 50.8% | 32.4% | 21.7% |
| Operating Income (EBIT) | ($291M) | ($310M) | ($222M) | ($446M) | ($541M) | ($468M) | ($216M) | ($116M) | ($115M) | ($134M) | ($96M) | ($60M) | $1M | ($25M) | ($19M) |
| Operating Margin % | -10.8% | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | 0.4% | -45.8% | -134.8% |
| Net Income | ($193M) | ($208M) | ($190M) | ($435M) | ($548M) | ($472M) | ($230M) | ($125M) | ($128M) | ($136M) | ($96M) | ($70M) | ($5M) | ($37M) | ($76M) |
| Net Margin % | -7.1% | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | -3.2% | -67.3% | -534.5% |
| EBITDA | — | ($221M) | ($148M) | ($383M) | ($507M) | ($452M) | ($206M) | ($104M) | ($107M) | ($126M) | ($93M) | ($61M) | $4M | ($23M) | ($18M) |
| Earnings Per Share (EPS) | $-1.36 | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.54 | $-1.86 | $-1.47 | $-0.14 | $-1.01 | $-24.37 |
| Shares Outstanding (M) | — | 137M | 125M | 115M | 98M | 91M | 81M | 70M | 58M | 54M | 52M | 48M | 37M | — | 3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M |
| Gross Profit | $485M | $451M | $447M | $384M | $347M | $317M | $300M | $272M | $243M |
| Gross Margin % | 64.4% | 64.8% | 67.1% | 64.9% | 63.5% | 63.2% | 62.9% | 61.8% | 58.8% |
| Operating Income (EBIT) | ($76M) | ($94M) | ($23M) | ($98M) | ($110M) | ($79M) | ($65M) | ($39M) | ($44M) |
| Operating Margin % | -10.1% | -13.4% | -3.4% | -16.5% | -20.2% | -15.8% | -13.6% | -8.9% | -10.6% |
| Net Income | ($67M) | ($85M) | $47M | ($88M) | ($101M) | ($67M) | ($54M) | ($32M) | ($37M) |
| Net Margin % | -8.9% | -12.2% | 7.1% | -14.8% | -18.5% | -13.3% | -11.3% | -7.2% | -9.1% |
| EBITDA | — | ($65M) | $8M | ($76M) | ($90M) | ($57M) | ($46M) | ($20M) | ($26M) |
| Earnings Per Share (EPS) | $-0.47 | $-0.60 | $0.35 | $-0.64 | $-0.74 | $-0.50 | $-0.43 | $-0.26 | $-0.30 |
| Shares Outstanding (M) | — | 142M | 137M | 137M | 136M | 135M | 125M | 124M | 123M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $228M | $215M | $136M | ($247M) | ($432M) | ($335M) | ($183M) | ($63M) | ($71M) | ($98M) | ($74M) | ($38M) | $10M | ($24M) | ($15M) |
| Capital Expenditures (CapEx) | $156M | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | $8M | $5M |
| Free Cash Flow (FCF) | $71M | $109M | $69M | ($286M) | ($479M) | ($376M) | ($202M) | ($68M) | ($74M) | ($108M) | ($97M) | ($46M) | $1M | ($32M) | ($19M) |
| FCF Margin % | 2.6% | 4.7% | 4.1% | -26.4% | -58.4% | -60.2% | -51.7% | -22.6% | -28.9% | -51.0% | -44.8% | -24.0% | 0.3% | -58.7% | -136.8% |
| Dividends Paid | — | — | — | — | $30M | — | $7M | — | — | $0M | $3M | $0M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M |
| Capital Expenditures (CapEx) | $63M | $22M | $36M | $35M | $26M | $22M | $18M | $16M | $12M |
| Free Cash Flow (FCF) | ($9M) | $18M | $38M | $24M | $12M | $23M | $35M | $35M | ($8M) |
| FCF Margin % | -1.2% | 2.6% | 5.7% | 4.1% | 2.1% | 4.5% | 7.3% | 8.1% | -1.9% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.7B | $2.5B | $1.7B | $1.4B | $1.4B | $1.2B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | $60M | $13M |
| Cash & Cash Equivalents | $1.1B | $1.1B | $946M | $642M | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | $30M | $6M |
| Total Liabilities | $836M | $796M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $295M | $231M | $139M |
| Total Debt (Short + Long-Term) | — | $96M | $91M | $375M | $370M | $336M | $260M | $130M | $124M | $123M | $50M | $42M | $27M | $24M | $132M |
| Total Shareholders' Equity | $1.8B | $1.7B | $1.2B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $106M | $185M | ($171M) | ($172M) | ($126M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NTRA viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms